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Over the past decade it was discovered that, over-and-above multiple regulatory functions, nitric oxide (NO) is responsible for the
modulation of cell respiration by inhibiting cytochrome c oxidase (CcOX). As assessed at different integration levels (from the purified
enzyme in detergent solution to intact cells), CcOX can react with NO following two alternative reaction pathways, both leading to an
effective, fully reversible inhibition of respiration. A crucial finding is that the rate of electron flux through the respiratory chain controls the
mechanism of inhibition by NO, leading to either a ‘‘nitrosyl’’ or a ‘‘nitrite’’ derivative. The two mechanisms can be discriminated on the
basis of the differential photosensitivity of the inhibited state. Of relevance to cell pathophysiology, the pathway involving the nitrite
derivative leads to oxidative degradation of NO, thereby protecting the cell from NO toxicity. The aim of this work is to review the
information available on these two mechanisms of inhibition of respiration.
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Nitric oxide (NO) is a fundamental second messenger
involved in a number of pathophysiological processes,
including vasodilatation, platelet aggregation, apoptosis
and neurotransmission [1–4]. In addition, NO has been
recognized as a potential signaling molecule controlling cell
respiration [5]. Among the respiratory complexes affected
by NO, cytochrome c oxidase (CcOX) is of particular
interest. NO inhibition of complex IV is rapid (milliseconds
to seconds), potent and reversible [6,7]; moreover, the
inhibition efficiency depends on the relative concentrations
of O2 and NO. On the other hand, other respiratory com-
plexes are inhibited more slowly (several minutes to hours)
and at higher, non-physiological, NO concentrations (for
some complexes in the millimolar range). Owing to the
potential pathophysiological significance of the inhibition of
respiration by NO, we have investigated the molecular
mechanisms of its reaction with CcOX at different integra-0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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respiring cells. This paper aims at reviewing the information
available on this issue.
Endogenous NO is enzymatically produced by NO
synthase (NOS) [8], an enzyme existing in three distinct
NOSs isoforms named, respectively, neuronal (nNOS or
type I-NOS), inducible (iNOS or type II-NOS) and endo-
thelial (eNOS or type III-NOS). Interestingly, NO is also
produced at the level of the mitochondrion by a mitochon-
drial NOS (mtNOS), discovered in the middle 1990s based
on immunocytochemical evidence [9–12]. Consistently,
mitochondria supplemented with L-arginine were able to
produce significant amounts of NO [13]. Since its discovery,
it has been debated whether this enzyme was representing a
fourth NOS isoform: however, in 1997 Ghafourifar and
Richter [14] showed that this mitochondrion-bound NOS
was functionally active and Ca2 +-dependent, as for nNOS
and eNOS. Later, Kanai et al. [15] reported that cardiomyo-
cytes from nNOS-knockout mice do not produce NO in the
mitochondrion, contrary to wild-type, concluding that the
mtNOS is actually a nNOS. More recently this information
was confirmed by a biochemical characterization of the
isolated enzyme [16]. The existence of a mitochondrial
source of NO further suggests a potential bioenergetic role
½M. Brunori et al. / Biochimica et Biophysica Acta 1655 (2004) 365–371366for NO in the control of energy transduction, in so far as a
mitochondrial production of NO may modulate the electron
flux levels through the respiratory chain.
Following the 1990 observation by Carr and Ferguson
[17] that NO catalytically generated by the Paracoccus
denitrificans nitrite reductase was able to inhibit the respi-
ration of bovine heart submitochondrial particles, clear-cut
evidence showing that NO controls cell respiration was
published in 1994 [18–20]. The target enzyme of this
inhibitory pattern is CcOX, as supported by the finding
that the extent of NO inhibition depends on O2 concentra-
tion (KI = 60 nM at [O2] = 30 AM [19]), showing competi-
tion. Since then, a great body of evidence has been
accumulated showing that NO inhibits cell respiration by
reacting with CcOX at all integration levels, including
mitochondria [18–20], cells [21–24] and tissues [25,26],
up to in vivo [27,28]. Work on isolated CcOX in detergent
solution allowed to assess that at physiological concentra-
tions NO reacts with the metals in the binuclear active site,
namely heme a3 and CuB, in different redox states. Reduced
heme a3 binds NO very quickly and with extremely high
affinity, the reaction yielding the typical Fe2 +-NO nitrosyl-
adduct [29,30]:
½a2þ3 CuþB  þ NOV ½a2þ3  NO CuþB  ð1Þ
While in the mitochondrial enzyme this reaction is a
straight ligand binding, in some prokaryotic oxidases it is
associated to the reduction of NO to N2O [31–33], in a
more complex process. A different reaction was shown toFig. 1. Reactions of NO with the catalytic intermediates of CcOX. NO reacts wit




2 +]. Upon binding to reduced heme a3 (interme
accumulated.occur between NO and oxidized CuB, whereby NO is
oxidized to nitrite, presumably via the transient formation
of a nitrosonium ion (NO+) [34]:
a3þ3 Cu
2þ
B  þ NO ! ½a3þ3 CuþBNOþ ! ½a3þ3 NO2 Cu2þB  ð2Þ
Both reactions lead to a reversible enzyme inhibition,
with formation of either a nitrosyl Fe2 + adduct or a nitrite-
derivative. These two inhibited states of CcOX display
very different light-sensitivity, because only the nitrosyl
derivative is photosensitive and can therefore be dissoci-
ated by illumination. Taking advantage of this property, a
simple experimental protocol was set up in our laboratory
to assess the predominance of each pathway as a function
of CcOX integration level and specific experimental
conditions.2. The reactions of NO with CcOX intermediates
The view emerging from an extensive investigation of
the reactions of NO with the catalytic intermediates of
CcOX is that a reaction occurs with either the reduced
heme a3 or the oxidized CuB. In Fig. 1, the canonical
catalytic intermediates, each containing these two metals
in the corresponding redox state, are schematically shown
only for the binuclear center. According to a consensus
simplified scheme, the catalytic cycle of CcOX can be
divided into a reductive and an oxidative limb [35–37]. Inh the catalytic intermediates of CcOX (indicated here only at the binuclear
f oxidized CuB (intermediates O, P and F) NO yields the light-insensitive,
diates E1 and R), the light-sensitive nitrosyl derivative [a3
2 +-NO CuB
+] is
Fig. 2. Light effect on the recovery of CcOX activity. (Top) Schematic
representation of the protocol used by Sarti et al. [50]. CcOX-catalyzed O2
consumption is inhibited upon addition of NO. When free NO is scavenged
by addition of excess oxy-Hb, the time course of respiration recovery is
followed both in the dark and under illumination. The recovery pattern
shown in the figure is characteristic of the light-sensitive ‘‘nitrosyl’’
inhibitory pathway: in the dark, recovery is rate-limited by the slow thermal
dissociation of NO from Fe2 +, as indicated by the pronounced lag-time;
under illumination the recovery rate is accelerated and the lag vanishes.
(Bottom) CcOX inhibition assessed as the rate at t = 50 s, after removal of
free NO by oxy-Hb addition, as measured in the dark and under
illumination. At lower cytochrome c concentrations, the recovery of
activity at 50 s is already complete and not influenced by light, pointing to
the accumulation of the ‘‘nitrite’’ CcOX derivative; at higher cytochrome c
concentrations, the extent of CcOX inhibition is considerably higher in the
dark, but vanishes under illumination, because of photodissociation of the
light-sensitive nitrosyl Fe2 +-NO adduct.
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electrons sequentially from CuA via cytochrome a. This
intra-molecular electron transfer, eventually yielding the
fully reduced site R, proceeds with the formation of half-
reduced intermediate E, with the electron residing either
on heme a3 (species E1) or on CuB (species E2). The rate-
determining step in the overall catalytic cycle is the
complete reduction of the binuclear site [38,39], which
is mandatory for the binding of O2. Then O2 is activated
and reduced [40] through the much faster oxidative limb
of the cycle (microseconds vs. milliseconds) restoring the
initial O state via the intermediates P and F [35–37].
Although the fine structure of intermediates P and F is still
somewhat debated, it is agreed that both are oxo-ferryl
adducts [41].1
Intermediates O, P and F contain CuB in the oxidized
state and, accordingly, they all react with NO following the
‘‘nitrite’’ reaction pathway (see Fig. 1) [34,42–44]; R is
characterized by a fully reduced binuclear center, which was
shown long ago [45] to bind NO very rapidly, yielding the
nitrosyl Fe2 + adduct. More difficult was to assess the
reactivity of the half-reduced E1 and E2 intermediates.
2.1. The reaction of NO with oxidized CuB (intermediates O,
P and F)
The reaction of NO with the oxidized enzyme (O),
investigated by Brudvig et al. in 1980 [46], involves
oxidized CuB as the reactive metal. However, in those
days, CcOX was generally purified in the so-called ‘‘rest-
ing’’ or ‘‘slow’’ state, characterized by an active site slowly
reacting with exogeneous ligands. The mechanism and the
functional relevance of this NO reaction was clarified only
in 1997 when Cooper et al. [34], using a so-called ‘‘fast/
pulsed’’ preparation of CcOX [47], reported that NO could
rapidly react with CuB in the oxidized enzyme, a reaction
prevented in the presence of bound chloride [42]. In the
overall process NO is oxidized to nitrite, which then binds
to the binuclear site, yielding an inhibited enzyme that upon
reduction recovers activity, releasing nitrite in the bulk
[44,48]. The reaction of NO with P and F was extensively
studied using optical spectroscopy [43,44] and amperom-
etry [44]; both intermediates were found to react at a rate
similar to, but smaller than for O (kc 104/105 M 1 s 1 at
20 jC, [43,44]), yielding the same nitrite-inhibited deriva-
tive. Relevant to cell physiology, the reaction of NO with
O, P and F yields nitrite, which is then released into the
medium; therefore this pathway represents an oxidative
degradation mechanism, disposing of toxic NO into harm-
less nitrite.1 By reacting with O2, the CO-bound two-electron reduced CcOX (so-
called mixed-valence-CO adduct) forms PM, whereas the fully reduced
enzyme (R) forms PR. The reactivity of the short-lived PR intermediate with
NO is essentially unknown so far, therefore throughout this review P stands
for PM.2.2. The reaction of NO with reduced heme a3 (intermedi-
ates R and E1)
In the early 1960s Gibson and Greenwood [45] charac-
terized from a kinetic viewpoint the reaction of NO with the
reduced enzyme R. NO was shown to bind to reduced heme
a3 very quickly (k = 0.4–1.0 108 M 1 s 1 at 20 jC,
[45,49]), yielding a tight, photosensitive nitrosyl Fe2 +
complex. The resulting inhibited derivative recovers activity
via dissociation of NO from the binuclear site, a process that
occurs slowly in the dark (kV= 4 10 3 s 1 at 20 jC), but
that is accelerated by illumination [50]. At first glance,
binding of NO to the reduced heme a3 may seem to account
for the efficient inhibition of CcOX, as well as for the
competition between NO and O2, which binds exclusively
to the fully reduced state R. However, given that the rate
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kinetics of inhibition may be difficult to rationalize, al-
though the data are not necessarily inconsistent with the
small inhibition constant (KI = 60 nM at [O2] = 30 AM, [19]).
Therefore it was proposed [29,30] that, in contrast to O2,
NO can also bind to a half-reduced binuclear site, E,
yielding the heme a3
2 +-NO complex. Computer simulations
[30] indicated that the additional reacting species E1 (unique
to NO) may be sufficient to account for the kinetic efficien-
cy of the inhibition, as well as the observed competition
between O2 and NO. In support of this hypothesis, consis-
tent experimental evidence was obtained quite recently, by
investigating the reduction kinetics of the K354M mutant of
P. denitrificans CcOX in the presence of NO [51]. Needless
to say, it would be desirable to device a procedure to obtain
CcOX stabilized in the E state, i.e. with a single-electron in
the active site, a task which seems at present unfulfilled.
In summary, the reaction pathway involving NO binding/
dissociation from Fe2 + of heme a3 accounts for the func-
tional inhibition and O2 competition of mitochondrial
CcOX, but it should be stressed that NO is temporarily
sequestered on the enzyme to be slowly dissociated in the
medium as free, reactive radical.3. Inhibition under turnover conditions
The overall picture emerging from the study of the
reactions of NO with the catalytic intermediates of CcOX
envisages that two possible derivatives can be formed when
the enzyme is exposed to NO, i.e. the Fe2 +-nitrosyl [a3
2 +-
NO] or the nitrite-derivative [a3
3 + NO2
CuB
2 +]. The next
relevant question is concerned with the predominance of
each of the two pathways under turnover conditions. ThisFig. 3. The two mechanisms of CcOX inhibition by NO. At low electron flux th
leading to an oxidative degradation of NO under turnover conditions. At higher
dissociation at reduced heme a3, prevails; only the latter pathway accounts for thissue was addressed by Sarti et al. [50], who designed an
experimental protocol based on the well-known photosen-
sitivity of the a3
2 +-NO complex [52], to discriminate the
formation of this adduct from the light-insensitive nitrite
complex. This experimental protocol, initially applied to
purified CcOX in detergent solution [50], was recently
extended to the enzyme integrated in the membrane, using
either mitochondria or intact cells. A scheme of the exper-
iment is shown in Fig. 2 (top panel). Typically, CcOX is
allowed to respire in an O2-electrode vessel until NO is
added and respiration is inhibited. After removal of free NO
by addition of excess oxy-hemoglobin (Hb), the time course
of respiration recovery is followed both in the dark and
under illumination. If the ‘‘nitrosyl’’ inhibition pathway is
predominant, the recovery of respiration in the dark pro-
ceeds at the slow rate characteristic of thermal NO dissoci-
ation from Fe2 +, and the overall time course is autocatalytic;
on the other hand, under illumination, the recovery of
respiration is accelerated due to the photochemically in-
duced dissociation of the nitrosyl adduct, and thus the lag
time vanishes. In contrast to this pattern, it was shown [50]
that if the nitrite-inhibited adduct accumulates, respiration
recovery (after scavenging free NO) is promptly restored by
reduction of the enzyme, but the O2 consumption rate is not
affected by illumination.
Working with the purified enzyme, it was shown [50]
that the predominance of one pathway over the other
depends on the concentration of reductants (notably reduced
cytochrome c) sustaining respiration (Fig. 2, bottom panel).
When turnover is sustained by a low concentration of
cytochrome c2+, following removal of free NO the recovery
is almost immediate (no lag time in the O2 electrode
recording) and light-insensitive, as expected if the nitrite-
adduct was the prevailing inhibited state [50]. At higherrough the respiratory chain, CcOX is inhibited via the ‘‘nitrite’’ pathway,
electron flux, the ‘‘nitrosyl’’ inhibition pathway, associated to NO binding/
e observed O2/NO competition.
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recovery in the dark occurs at a rate compatible with the off-
rate of NO from the light-sensitive heme a3
2 +-NO adduct,
and consistently is accelerated by illumination [52]. In
summary, at low electron flux nitrite inhibits the oxidase
by forming an adduct with the oxidized heme a3, whereas at
higher electron flux the inhibited state is NO-bound to
reduced CcOX.
The existence of these two reaction pathways has been
substantiated spectroscopically, using soluble CcOX [50]. As
schematically depicted in Fig. 3, available evidence suggests
that the electron flux through the enzyme controls the
predominance of one or the other of the two inhibition
mechanisms. During steady-state, a slow rate of electron flux
through CcOX increases the overall occupancy of the inter-
mediates having oxidized CuB (O, P and F, see Ref. [44]), and
thereby the ‘‘nitrite’’ inhibition pathway prevails. On the
contrary, at higher electron fluxes the probability of forming
the nitrosyl Fe2 +-NO adduct increases, due to the intrinsi-
cally rapid decay of the partially oxidized intermediates [36].
It may be asked whether the existence of these two
reaction pathways is somehow artefactually restricted to
the purified enzyme in detergent solution. To address this
problem, we have investigated the inhibition by NO using
isolated mitochondria and cell suspensions. Our results
[53] fully confirm that the existence of the two aforemen-
tioned inhibitory pathways is not confined to purified
CcOX, but is a property of the enzyme integrated in its
native membrane.4. Relevance to cell pathophysiology
NO is a Janus molecule, since depending on its intracel-
lular concentration, it may act as a physiological signaling
molecule or as a toxic agent. This is also applicable to its
reactions with the respiratory chain, which may be physio-
logically modulated at relatively low NO mitochondrial
fluxes, but severely affected by higher, toxic concentrations.
It is known that NO inhibition of mitochondrial respiration
has a role in cell death, by either necrotic or apoptotic
mechanisms (see Refs. [3,54] for reviews). Moreover, NO
toxicity in the extreme is mediated by the reactive perox-
initrite species (ONOO), formed by the reaction of NO
with the superoxide anion; unlike NO, peroxinitrite is
indeed causing an irreversible inactivation of respiration.
A strict control of intracellular NO may therefore be
welcome by the cell.
A physiologically meaningful discussion of the role of
NO in the control of respiration cannot ignore the problem
of compartmentalization of the NO production, under
physiological and pathological conditions. In this perspec-
tive, the demonstration of a mtNOS [9–16] acquires special
significance and demands some additional considerations.
If the density of mtNOS, which is bound to the inner
membrane, was comparable to that of the respiratorycomplexes, then the flux of NO in situ could be sufficient
to inhibit a substantial fraction of CcOX under normal
turnover conditions. The high solubility of NO in mem-
branes would enhance the probability of encounter with the
oxidase and thus of inhibition of respiration, provided that
the concentration of L-Arg is sufficient to support a steady
flux of NO. This would account for the classical observa-
tion that the KM for O2 measured in tissues is manifold
greater than that of purified CcOX or isolated mitochondria,
as lucidly pointed out by Brown [5]. Thus, it may be
envisaged that, under normal metabolic conditions, a con-
siderable fraction of oxidase is inhibited, which would have
the effect of extending O2 availability either to cells at
different distances from capillaries [16], or within the
mitochondrion, allowing O2 utilization by as many as
possible respiratory enzyme complexes, differently distrib-
uted in space within the organelle. Within this perspective,
the release of NO by dissociation from the a3
2 +-NO com-
plex (through one of the inhibitory pathways discussed
above) may extend the range of action of NO and thus the
effective range of O2 utilization. On the other hand, the
inhibitory pathway involving the formation of the nitrite
adduct leads to termination of NO and thus may break
propagation. The nitrite-mediated pathway is therefore a
mechanism of degradation of NO to harmless nitrite, which
is operative in the cell as one of the physiological systems
scavenging NO, predominantly in the limit of reduced
electron flux.Acknowledgements
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